Chronic gastroparesis — long-term management
Gastroparesis · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Delayed gastric emptying without mechanical obstruction, causing early satiety, nausea, vomiting and bloating; most often diabetic, post-surgical or idiopathic. Management combines dietary measures, prokinetics and antiemetics.
Red flags
- Severe dehydration or electrolyte disturbance
- Rapid weight loss / inability to maintain nutrition
- Haematemesis or features of obstruction
- QT prolongation on prokinetics
Assessment
Differential diagnosis
- Mechanical gastric outlet obstruction
- Functional dyspepsia
- Cyclic vomiting / cannabinoid hyperemesis
- Rumination syndrome
- Medication effect (GLP-1 agonists, opioids)
- Superior mesenteric artery syndrome
Investigations
- Gastric emptying scintigraphy (4-hour solid-phase; gold standard)
- Upper endoscopy to exclude mechanical obstruction
- HbA1c and glucose optimisation review
- U&E, nutritional markers, weight trend
- Review culprit drugs (opioids, anticholinergics, GLP-1 agonists)
Management
- Confirm delayed emptying and exclude mechanical obstruction with endoscopy
- Optimise glycaemic control in diabetics (hyperglycaemia slows emptying)
- Stop or reduce medications that delay emptying (opioids, anticholinergics, GLP-1 analogues)
- Dietary measures: small frequent low-fat, low-fibre meals; more liquid calories if severe
- Start a prokinetic — metoclopramide first-line, time-limited to minimise tardive dyskinesia risk
- Add antiemetics for symptom control (ondansetron, prochlorperazine)
- Consider domperidone (ECG/QT check) or erythromycin for refractory cases
- Ensure hydration and nutritional support; involve dietitian
- For refractory disease consider gastric electrical stimulation, G-POEM, or jejunal feeding at specialist centre
- Monitor weight, electrolytes and symptom scores
- Screen for and treat overlapping anxiety/depression affecting symptom burden
Drugs & doses
Metoclopramide 10 mg PO three times daily (limit ≤12 weeks)
Domperidone 10 mg PO three times daily (QT/ECG caution)
Erythromycin 125–250 mg PO three times daily (short-term, tachyphylaxis)
Ondansetron 4–8 mg PO/IV up to three times daily
Prochlorperazine 5–10 mg PO three times daily
Disposition
Outpatient GI and dietitian management; tertiary referral for refractory disease and feeding/neurostimulation options.
Complications & pitfalls
- Malnutrition and weight loss
- Dehydration and electrolyte disturbance
- Mallory-Weiss tear / bezoar
- Erratic glycaemic control
- Tardive dyskinesia from prolonged metoclopramide
Exam pearls
- Exclude GLP-1 receptor agonists and opioids as reversible causes before labelling idiopathic
- Limit metoclopramide to short courses because of tardive dyskinesia risk
- Tight glycaemic control itself improves gastric emptying in diabetics
- Liquid-calorie nutrition is tolerated better than solids in severe disease
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.